Variant report
Variant | esv3311720 |
---|---|
Chromosome Location | chr15:34989684-34990077 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:34983650..34987842-chr15:34989482..34992979,5 | K562 | blood: | |
2 | chr15:34988822..34991429-chr15:34996883..34999400,2 | K562 | blood: | |
3 | chr15:34989332..34992979-chr15:34995533..34998034,4 | K562 | blood: | |
4 | chr15:34983650..34987345-chr15:34990001..34992979,4 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138121601 | chr15:34989701-34989702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376827570 | chr15:34989707-34989708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561645773 | chr15:34989709-34989710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149329032 | chr15:34989756-34989757 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143577545 | chr15:34989770-34989771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564981144 | chr15:34989772-34989773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532370984 | chr15:34989803-34989804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34318635 | chr15:34989848-34989849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11073060 | chr15:34989851-34989852 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
10 | rs568606848 | chr15:34989956-34989957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188139661 | chr15:34989960-34989961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367594859 | chr15:34989963-34989964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192642914 | chr15:34989980-34989981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548877871 | chr15:34989988-34989989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551495152 | chr15:34990015-34990016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185421241 | chr15:34990074-34990075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574051998 | chr15:34990075-34990076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
HDAC8 | 0 | CNVD |
NIPBL | 0 | CNVD |
RAD21 | 0 | CNVD |
SMC1A | 0 | CNVD |
SMC3 | 0 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Angelman syndrome | 16183798 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Abnormal corpus callosum | 21572526 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 19204725 | CNVD |
Schizophrenia | 19204725 | CNVD |
Schizophrenia | 19149910 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Legius syndrome | 19443465 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prader-willi syndrome | 21504564 | CNVD |
Cancer | 17440070 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:34986200-34991600 | Weak transcription | HUVEC | blood vessel |
2 | chr15:34988600-34989800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr15:34988800-34989800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr15:34989000-34990200 | Enhancers | K562 | blood |
5 | chr15:34989000-34993800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr15:34989200-34989800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr15:34989200-34990000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr15:34989200-34990000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr15:34989400-34989800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr15:34989600-34993800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr15:34989800-34993800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr15:34990000-34993800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |